A startup seeking to replace animal testing with a sophisticated high-tech platform has raised $40 million to develop ...

Boundless Bio is in a bind. A phase 1/2 trial has revealed the shortcomings of Boundless’ lead candidate, prompting the ...

Shuttle-based therapies are under active development for an array of brain conditions. “It’s now abundantly clear that we can ...

The Grant Watch database Scott Delaney helped set up has been used to better understand the implications of grant ...

A new year means a new Fierce Biotech Fundraising Tracker to record the significant amounts of venture capital being funneled into the industry. We're maintaining the criteria we used for last ...

Only time will tell, and you must research carefully before spending your hard-earned money. Modern biotechnology began in 1973 when scientists used recombination to genetically engineer an ...

Computational biology and bioinformatics is an interdisciplinary field that develops and applies computational methods to analyse large collections of biological data, such as genetic sequences ...

Intellia's drug was designed to correct a mutation in the SERPINA1 gene that codes for AAT and has been discontinued along with other "select research-stage programmes," according to the company ...

Strand Therapeutics reports early positive data for STX-001, a self-replicating mRNA cancer therapy, showing safety and ...

The challenges facing biotechs amid the ongoing financial fallout have resulted in the winding down of one US biotech, Vor Bio, and job losses at a clutch of other firms. Cambridge, Massachusetts ...